VA
AXNX

Verdad Advisers’s Axonics, Inc. Common Stock AXNX Stock Holding History

Verdad Advisers’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$267K Buy
+3,842
New +$263K 0.36% 90

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Verdad Advisers's AXNX Position: Q3 2024 in Review

Verdad Advisers opened a new position in Axonics, Inc. Common Stock (AXNX) in Q3 2024: 3,842 shares worth $267K. The stake represents 0.36% of the portfolio and ranks #90 among its holdings.

233 funds tracked by Wall St. Rank hold AXNX as of Q3 2024.

  • Verdad Advisers held 3,842 shares of Axonics, Inc. Common Stock worth $267K as of Q3 2024.
  • Axonics, Inc. Common Stock was a new Verdad Advisers position in Q3 2024.
  • Axonics, Inc. Common Stock made up 0.36% of Verdad Advisers's portfolio in Q3 2024, its #90 holding.
  • 233 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2024.

Based on Verdad Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.